ASHIMA ANEJA: Open Payments
NPI 1851711022 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 24 payments from 10 companies in 2025. Trend: 2023 $266 · 2024 $440 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: VRAYLAR, COBENFY, CAPLYTA, SPRAVATO, Qelbree, HETLIOZ, TRINTELLIX, Auvelity.
Industry payments across NC — which companies pay providers there.
